+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Insomnia Therapeutics Market 2025-2029- Product Image
Insomnia Therapeutics Market 2025-2029- Product Image
New

Insomnia Therapeutics Market 2025-2029

  • PDF Icon

    Report

  • 205 Pages
  • July 2025
  • Region: Global
  • TechNavio
  • ID: 5887149
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The insomnia therapeutics market is forecasted to grow by USD 1.19 billion during 2024-2029, accelerating at a CAGR of 5.9% during the forecast period. The report on the insomnia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of insomnia, technological advancements in diagnostics and treatment, and rising healthcare expenditure and insurance coverage.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The insomnia therapeutics market is segmented as below:

By Type

  • Drug
  • Devices

By Distribution Channel

  • Prescription
  • OTC

By Drug Class

  • Non-benzodiazepines
  • Benzodiazepines
  • Antidepressants
  • Orexin receptor antagonists
  • Melatonin receptor agonists

By Geographical Landscape

  • North America
  • Asia
  • Europe
  • Rest of World (ROW)
This study identifies the increased focus on non-pharmacological treatments as one of the prime reasons driving the insomnia therapeutics market growth during the next few years. Also, technological advancements in sleep monitoring and tracking and growing awareness and acceptance of importance of mental health will lead to sizable demand in the market.

The report on the insomnia therapeutics market covers the following areas:

  • Insomnia Therapeutics Market sizing
  • Insomnia Therapeutics Market forecast
  • Insomnia Therapeutics Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insomnia therapeutics market vendors that include Abbott Laboratories, Astellas Pharma Inc., Aurobindo Pharma Ltd., Eisai Co. Ltd., Electromedical Products International Inc., Idorsia Pharmaceuticals Ltd., INNOVATIVE NEUROLOGICAL DEVICES LLC, Mallinckrodt Plc, MEDICE Arzneimittel Putter GmbH and Co. KG, Merck and Co. Inc., Neurim Pharmaceuticals Ltd., Pfizer Inc., Sanofi SA, Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vanda Pharmaceuticals Inc., and Viatris Inc. Also, the insomnia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Insomnia Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Insomnia Therapeutics Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Drug Class segment analysis 2019 - 2023
Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The impact of AI in the global insomnia therapeutics market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Drug - Market size and forecast 2024-2029
Chart on Drug - Market size and forecast 2024-2029 ($ million)
Data Table on Drug - Market size and forecast 2024-2029 ($ million)
Chart on Drug - Year-over-year growth 2024-2029 (%)
Data Table on Drug - Year-over-year growth 2024-2029 (%)
8.4 Devices - Market size and forecast 2024-2029
Chart on Devices - Market size and forecast 2024-2029 ($ million)
Data Table on Devices - Market size and forecast 2024-2029 ($ million)
Chart on Devices - Year-over-year growth 2024-2029 (%)
Data Table on Devices - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Prescription - Market size and forecast 2024-2029
Chart on Prescription - Market size and forecast 2024-2029 ($ million)
Data Table on Prescription - Market size and forecast 2024-2029 ($ million)
Chart on Prescription - Year-over-year growth 2024-2029 (%)
Data Table on Prescription - Year-over-year growth 2024-2029 (%)
9.4 OTC - Market size and forecast 2024-2029
Chart on OTC - Market size and forecast 2024-2029 ($ million)
Data Table on OTC - Market size and forecast 2024-2029 ($ million)
Chart on OTC - Year-over-year growth 2024-2029 (%)
Data Table on OTC - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Drug Class
10.1 Market segments
Chart on Drug Class - Market share 2024-2029 (%)
Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
10.3 Non-benzodiazepines - Market size and forecast 2024-2029
Chart on Non-benzodiazepines - Market size and forecast 2024-2029 ($ million)
Data Table on Non-benzodiazepines - Market size and forecast 2024-2029 ($ million)
Chart on Non-benzodiazepines - Year-over-year growth 2024-2029 (%)
Data Table on Non-benzodiazepines - Year-over-year growth 2024-2029 (%)
10.4 Benzodiazepines - Market size and forecast 2024-2029
Chart on Benzodiazepines - Market size and forecast 2024-2029 ($ million)
Data Table on Benzodiazepines - Market size and forecast 2024-2029 ($ million)
Chart on Benzodiazepines - Year-over-year growth 2024-2029 (%)
Data Table on Benzodiazepines - Year-over-year growth 2024-2029 (%)
10.5 Antidepressants - Market size and forecast 2024-2029
Chart on Antidepressants - Market size and forecast 2024-2029 ($ million)
Data Table on Antidepressants - Market size and forecast 2024-2029 ($ million)
Chart on Antidepressants - Year-over-year growth 2024-2029 (%)
Data Table on Antidepressants - Year-over-year growth 2024-2029 (%)
10.6 Orexin receptor antagonists - Market size and forecast 2024-2029
Chart on Orexin receptor antagonists - Market size and forecast 2024-2029 ($ million)
Data Table on Orexin receptor antagonists - Market size and forecast 2024-2029 ($ million)
Chart on Orexin receptor antagonists - Year-over-year growth 2024-2029 (%)
Data Table on Orexin receptor antagonists - Year-over-year growth 2024-2029 (%)
10.7 Melatonin receptor agonists - Market size and forecast 2024-2029
Chart on Melatonin receptor agonists - Market size and forecast 2024-2029 ($ million)
Data Table on Melatonin receptor agonists - Market size and forecast 2024-2029 ($ million)
Chart on Melatonin receptor agonists - Year-over-year growth 2024-2029 (%)
Data Table on Melatonin receptor agonists - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.5 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.11 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.12 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.13 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.14 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.15 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key offerings
SWOT
15.5 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
SWOT
15.6 Eisai Co. Ltd.
Eisai Co. Ltd. - Overview
Eisai Co. Ltd. - Business segments
Eisai Co. Ltd. - Key offerings
Eisai Co. Ltd. - Segment focus
SWOT
15.7 Electromedical Products International Inc.
Electromedical Products International Inc. - Overview
Electromedical Products International Inc. - Product / Service
Electromedical Products International Inc. - Key offerings
SWOT
15.8 Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. - Overview
Idorsia Pharmaceuticals Ltd. - Product / Service
Idorsia Pharmaceuticals Ltd. - Key offerings
SWOT
15.9 INNOVATIVE NEUROLOGICAL DEVICES LLC
INNOVATIVE NEUROLOGICAL DEVICES LLC - Overview
INNOVATIVE NEUROLOGICAL DEVICES LLC - Product / Service
INNOVATIVE NEUROLOGICAL DEVICES LLC - Key offerings
SWOT
15.10 Mallinckrodt Plc
Mallinckrodt Plc - Overview
Mallinckrodt Plc - Business segments
Mallinckrodt Plc - Key news
Mallinckrodt Plc - Key offerings
Mallinckrodt Plc - Segment focus
SWOT
15.11 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.12 Neurim Pharmaceuticals Ltd.
Neurim Pharmaceuticals Ltd. - Overview
Neurim Pharmaceuticals Ltd. - Product / Service
Neurim Pharmaceuticals Ltd. - Key offerings
SWOT
15.13 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.14 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.15 Sumitomo Pharma Co. Ltd.
Sumitomo Pharma Co. Ltd. - Overview
Sumitomo Pharma Co. Ltd. - Business segments
Sumitomo Pharma Co. Ltd. - Key offerings
Sumitomo Pharma Co. Ltd. - Segment focus
SWOT
15.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
15.18 Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. - Overview
Vanda Pharmaceuticals Inc. - Product / Service
Vanda Pharmaceuticals Inc. - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Insomnia Therapeutics Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Type
Exhibits 41: Data Table on Comparison by Type
Exhibits 42: Chart on Drug - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Drug - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Drug - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Drug - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Devices - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Devices - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Devices - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Devices - Year-over-year growth 2024-2029 (%)
Exhibits 50: Market opportunity by Type ($ million)
Exhibits 51: Data Table on Market opportunity by Type ($ million)
Exhibits 52: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 53: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 54: Chart on Comparison by Distribution Channel
Exhibits 55: Data Table on Comparison by Distribution Channel
Exhibits 56: Chart on Prescription - Market size and forecast 2024-2029 ($ million)
Exhibits 57: Data Table on Prescription - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Chart on Prescription - Year-over-year growth 2024-2029 (%)
Exhibits 59: Data Table on Prescription - Year-over-year growth 2024-2029 (%)
Exhibits 60: Chart on OTC - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on OTC - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on OTC - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on OTC - Year-over-year growth 2024-2029 (%)
Exhibits 64: Market opportunity by Distribution Channel ($ million)
Exhibits 65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 66: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits 67: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits 68: Chart on Comparison by Drug Class
Exhibits 69: Data Table on Comparison by Drug Class
Exhibits 70: Chart on Non-benzodiazepines - Market size and forecast 2024-2029 ($ million)
Exhibits 71: Data Table on Non-benzodiazepines - Market size and forecast 2024-2029 ($ million)
Exhibits 72: Chart on Non-benzodiazepines - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Non-benzodiazepines - Year-over-year growth 2024-2029 (%)
Exhibits 74: Chart on Benzodiazepines - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Benzodiazepines - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Benzodiazepines - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Benzodiazepines - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Antidepressants - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Antidepressants - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Antidepressants - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Antidepressants - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Orexin receptor antagonists - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Orexin receptor antagonists - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Orexin receptor antagonists - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Orexin receptor antagonists - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Melatonin receptor agonists - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Melatonin receptor agonists - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Melatonin receptor agonists - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Melatonin receptor agonists - Year-over-year growth 2024-2029 (%)
Exhibits 90: Market opportunity by Drug Class ($ million)
Exhibits 91: Data Table on Market opportunity by Drug Class ($ million)
Exhibits 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 95: Chart on Geographic comparison
Exhibits 96: Data Table on Geographic comparison
Exhibits 97: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 153: Market opportunity By Geographical Landscape ($ million)
Exhibits 154: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 155: Impact of drivers and challenges in 2024 and 2029
Exhibits 156: Overview on criticality of inputs and factors of differentiation
Exhibits 157: Overview on factors of disruption
Exhibits 158: Impact of key risks on business
Exhibits 159: Companies covered
Exhibits 160: Company ranking index
Exhibits 161: Matrix on companies position and classification
Exhibits 162: Astellas Pharma Inc. - Overview
Exhibits 163: Astellas Pharma Inc. - Product / Service
Exhibits 164: Astellas Pharma Inc. - Key offerings
Exhibits 165: SWOT
Exhibits 166: Aurobindo Pharma Ltd. - Overview
Exhibits 167: Aurobindo Pharma Ltd. - Product / Service
Exhibits 168: Aurobindo Pharma Ltd. - Key offerings
Exhibits 169: SWOT
Exhibits 170: Eisai Co. Ltd. - Overview
Exhibits 171: Eisai Co. Ltd. - Business segments
Exhibits 172: Eisai Co. Ltd. - Key offerings
Exhibits 173: Eisai Co. Ltd. - Segment focus
Exhibits 174: SWOT
Exhibits 175: Electromedical Products International Inc. - Overview
Exhibits 176: Electromedical Products International Inc. - Product / Service
Exhibits 177: Electromedical Products International Inc. - Key offerings
Exhibits 178: SWOT
Exhibits 179: Idorsia Pharmaceuticals Ltd. - Overview
Exhibits 180: Idorsia Pharmaceuticals Ltd. - Product / Service
Exhibits 181: Idorsia Pharmaceuticals Ltd. - Key offerings
Exhibits 182: SWOT
Exhibits 183: INNOVATIVE NEUROLOGICAL DEVICES LLC - Overview
Exhibits 184: INNOVATIVE NEUROLOGICAL DEVICES LLC - Product / Service
Exhibits 185: INNOVATIVE NEUROLOGICAL DEVICES LLC - Key offerings
Exhibits 186: SWOT
Exhibits 187: Mallinckrodt Plc - Overview
Exhibits 188: Mallinckrodt Plc - Business segments
Exhibits 189: Mallinckrodt Plc - Key news
Exhibits 190: Mallinckrodt Plc - Key offerings
Exhibits 191: Mallinckrodt Plc - Segment focus
Exhibits 192: SWOT
Exhibits 193: Merck and Co. Inc. - Overview
Exhibits 194: Merck and Co. Inc. - Business segments
Exhibits 195: Merck and Co. Inc. - Key news
Exhibits 196: Merck and Co. Inc. - Key offerings
Exhibits 197: Merck and Co. Inc. - Segment focus
Exhibits 198: SWOT
Exhibits 199: Neurim Pharmaceuticals Ltd. - Overview
Exhibits 200: Neurim Pharmaceuticals Ltd. - Product / Service
Exhibits 201: Neurim Pharmaceuticals Ltd. - Key offerings
Exhibits 202: SWOT
Exhibits 203: Pfizer Inc. - Overview
Exhibits 204: Pfizer Inc. - Product / Service
Exhibits 205: Pfizer Inc. - Key news
Exhibits 206: Pfizer Inc. - Key offerings
Exhibits 207: SWOT
Exhibits 208: Sanofi SA - Overview
Exhibits 209: Sanofi SA - Business segments
Exhibits 210: Sanofi SA - Key news
Exhibits 211: Sanofi SA - Key offerings
Exhibits 212: Sanofi SA - Segment focus
Exhibits 213: SWOT
Exhibits 214: Sumitomo Pharma Co. Ltd. - Overview
Exhibits 215: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits 216: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits 217: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits 218: SWOT
Exhibits 219: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 220: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 221: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 222: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 223: SWOT
Exhibits 224: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 225: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 226: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 227: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 228: SWOT
Exhibits 229: Vanda Pharmaceuticals Inc. - Overview
Exhibits 230: Vanda Pharmaceuticals Inc. - Product / Service
Exhibits 231: Vanda Pharmaceuticals Inc. - Key offerings
Exhibits 232: SWOT
Exhibits 233: Inclusions checklist
Exhibits 234: Exclusions checklist
Exhibits 235: Currency conversion rates for US$
Exhibits 236: Research methodology
Exhibits 237: Information sources
Exhibits 238: Data validation
Exhibits 239: Validation techniques employed for market sizing
Exhibits 240: Data synthesis
Exhibits 241: 360 degree market analysis
Exhibits 242: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global insomnia therapeutics market: Abbott Laboratories, Astellas Pharma Inc., Aurobindo Pharma Ltd., Eisai Co. Ltd., Electromedical Products International Inc., Idorsia Pharmaceuticals Ltd., INNOVATIVE NEUROLOGICAL DEVICES LLC, Mallinckrodt Plc, MEDICE Arzneimittel Putter GmbH and Co. KG, Merck and Co. Inc., Neurim Pharmaceuticals Ltd., Pfizer Inc., Sanofi SA, Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vanda Pharmaceuticals Inc., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increased focus on non-pharmacological treatments."

According to the report, one of the major drivers for this market is the increasing prevalence of insomnia.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Aurobindo Pharma Ltd.
  • Eisai Co. Ltd.
  • Electromedical Products International Inc.
  • Idorsia Pharmaceuticals Ltd.
  • INNOVATIVE NEUROLOGICAL DEVICES LLC
  • Mallinckrodt Plc
  • MEDICE Arzneimittel Putter GmbH and Co. KG
  • Merck and Co. Inc.
  • Neurim Pharmaceuticals Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Sumitomo Pharma Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Vanda Pharmaceuticals Inc.
  • Viatris Inc.

Related Topics

Related Reports

Insomnia Therapeutics Global Market Report 2025 - Product Image

Insomnia Therapeutics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Insomnia Drugs Market by Drug Class (Antihistamines, Benzodiazepines, Melatonin Receptor Agonists), Formulation (Capsules, Injectables, Oral Suspensions), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Insomnia Drugs Market by Drug Class (Antihistamines, Benzodiazepines, Melatonin Receptor Agonists), Formulation (Capsules, Injectables, Oral Suspensions), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Insomnia Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Insomnia Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 120 Pages
  • Global
From
Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Digital Insomnia Therapeutics Market Report 2025 - Product Image

Digital Insomnia Therapeutics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.